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Introduction: Delayed contrast enhanced Cardiac MRI has been accepted as a standard tool
worldwide for determination of infarcted myocardium and viability. Infarct size as deter-
mined by cardiac MRI has important therapeutic and prognostic information.
Methods: Twenty six STEMI patients who had received thrombolytic therapy were subjected
to cardiac MRI assessment at 5e7 day of admission. Base line variables of the study pop-
ulation were compared with the acute infarct size as determined by the Cardiac MRI.
Results: The mean acute infarct size in our study population was 27.2 ± 17.4% of LV. We
found through univariate analysis that final infarct size was dependent on time to
thrombolysis (p ¼ 0.04), Status of Thrombolysis (p ¼ 0.01), smoking status (p ¼ 0.02),
location of infarct (p < 0.00001), presence of microvascular obstruction (p ¼ 0.01) and
viability status (p ¼ 0.0004). Thus, larger acute infarct size was seen in delayed time to
thrombolysis, failed status of thrombolysis, smokers, anterior location of the infarct,
presence of microvascular obstruction and non viable myocardial status.
Conclusion: Infarct size as determined by Cardiac MRI has been shown to carry important
therapeutic and prognostic information. We have tried to evaluate predictors of acute
infarct on cardiac MRI in STEMI patients during their initial hospital stay. Knowing the
predictors of acute infarct size can help in early intervention and provide prognostic in-
formation for future cardiac events.
Copyright © 2015, Cardiological Society of India. All rights reserved.(V. Bhatia).
ciety of India. All rights reserved.
Grade 0 no enhancement
Grade I 25% tissue involvement
Grade II 26e50%
Grade III 51e75%
Grade IV 76e100%
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Cardiovascular MR (CMR) imaging has become a practical,
clinically useful tool for the non-invasive evaluation of
ischemic heart disease providing both structural and func-
tional information.1
It has also been shown that reversibly injuredmyocardium
does not result in increased myocardial gadolinium concen-
trations and, therefore, does not enhance whereas regions of
hyperenhancement accurately quantify nonviable
myocardium.2
Many studies have shown that infarct size correlates with
the remodeling, ejection fraction and future cardiac events
and determination of infarct size by cardiac MRI gives
important prognostic and therapeutic information.
Present study was done to the predictors of acute infarct
size in STEMI patients receiving thrombolytic therapy.2. Study population
The study was carried out in all consecutive patients of STEMI
who had received thrombolytic therapy admitted in the
Department of Cardiology over a period of one year.3. Cardiac MRI examination
Cardiac MRI examination was conducted in the following
manner. Cardiac Cine MRI was performed on 1.5 T Siemens
Somatom machine using dedicated phased array chest coil
after 5e7 days of hospital stay. Patient position was kept su-
pine. Prospective ECG gating was used in all the patients. Pre
contrast ECG gated GRE true FISP images in short axis, vertical
long axis planes and horizontal long axis were acquired.
Various imaging parameters were slice thickness ¼ 8 mm,
contiguous sections with no spacing; TE ¼ 1.33, TR ¼ 859.20,
FOV ¼ 340, Flip angle ¼ 40 and image matrix of 101  92. T1
scout imageswere acquired by selecting the slice atmid cavity
level and the appropriate myocardial nulling time was found
in each patient by both visual inspection and mean curve
method. Each patient was given 0.2 m mol/kg intravenous
Gadolinium followed by 20ml saline at a rate of 3 ml/s using a
pressure injector. ECG gated Dynamic post contrast images
were obtained with immediate and 20 min delayed acquisi-
tions using inversion recovery 3D GRE sequences and using
the appropriately selected time to inversion. Cine imageswere
acquired in the corresponding short-axis, vertical long-axis
views and horizontal long axis views. The acquisition of
short-axis views were started 1 cm below the level of the
mitralevalveeinsertion plane and continued in 8 mm in-
crements through the left ventricle.
Twelve equal circumferential segments were analyzed in
each short-axis view.
Delayed hyper enhancement was observed after 20 min on
post-contrast images. Enhanced area was defined as that
showing signal intensity at least 2 SD greater than normal
myocardium. The area of the infarction as depicted by delayed
contrast enhancement was calculated in each segment as:Area showing enhancement ¼ a
Area unenhanced ¼ b
Percentage of area enhanced in each segment ¼
a/(a þ b)  100.
The transmural extent of Infarction (TEI) within each
segment (expressed as percentage of the total segmental area)
was graded on a 5-point scale as follows:Total LV infarct size was calculated as Infarct size by DCE
MRI (%LV)¼ [Sumof all TEI scores throughout LV (range, 0e4)]/
(Total Number of segments  4).
Microvascular obstruction was defined as any hypo-
enhanced area present within the hyperenhanced infarcted
region on delayed contrast images.
Left ventricular functional parameters were calculated
using the Syngo Argus software and tracing the endocardial
borders in each of the short axis cine images. Left ventricular
ejection fraction, end diastolic and systolic volumes and
stroke volume were calculated for each patient. For calcula-
tion purposes the papillary muscles were considered to be
part of ventricular cavity.
All segments with enhancement in each patient were
noted and patients were divided into two groups; viable and
nonviable. The ratio of [Sum of all TEI scores throughout LV
segments showing enhancement (range, 0e4)]/(Total Number
of segments with enhancement) was noted in each patient.
Patients with score > 2 were considered to be having Non
viable myocardium (Fig. 1 and 2).
Patients with score < 2 were considered to be having viable
myocardium (Fig. 3).4. Statistical analysis
Student's t test was used to compare the means of the
continuous variables. Chi-square test was used to compare
the discrete variables. All analysis were performed with Epi
Info software. Univariate analysis was performed to see the
association of variables with acute infarct size.5. Results
Baseline characteristics of the study population is shown in
Table 1.
Univariate analysis for infarct size is shown in Table 2.
The mean acute infarct size in our study population was
27.2 þ 17.4% of LV. We found through univariate analysis that
final infarct size was dependent on time to thrombolysis
(p ¼ 0.04), Status of Thrombolysis (p ¼ 0.01), smoking status
(p ¼ 0.02), location of infarct (p < 0.00001), presence of
Fig. 1 e Short axis and vertical long axis delayed contrast enhanced images show anterior non viable infarct (red arrow).
There are areas of non enhancement within the infarcted core suggestive of microvascular obstruction (arrow head).
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(p ¼ 0.0004). Thus, larger infarct size was seen in delayed time
to thrombolysis, failed status of thrombolysis, smokers,
anterior location of the infarct, presence of microvascular
obstruction and non viable myocardial status.6. Discussion
Determination of myocardial viability is of paramount
importance. Multiple observational studies have suggested
survival benefit in such patients if they are revascularized
when myocardial viability is detected on imaging tests.
Wolfgang G. Rehwald et al2 have compared delayed
contrast enhancement with histopathological findings and
found that it accurately differentiates viable and non viable
regions.
Holger Thiele et al3 studied 360 consecutive STEMI patients
who were reperfused by primary PCI within 12 h after symp-
tom onset through delayed contrast enhanced cardiac MRIFig. 2 e Delayed contrast enhanced short axis and vertical long
arrows).performed 3.1± 4.1 days after the acute event. They found that
predictors of final infarct size were pre-PCI TIMI-flow grade,
infarct location, Killip class and 90 min ST-segment resolu-
tion. Like their results we also found that infarct size was
larger when located anterior than inferior. Our study also
correlated with their results that higher Killip class was
associated with larger infarct size. They also found that final
infarct size was inversely related to 90 min ST resolution
which correlated with the status of thrombolysis assessed by
us which included ST resolution as the marker for efficacy of
thrombolysis. The mechanism of reperfusion was different in
our studywhich included thrombolysis through streptokinase
whereas in their study it was primary PCI. In contrast to our
study the time-to-reperfusion did not affect infarct size in
their study. It is probably reflected by the difference in the
method of reperfusion between the two studies. They have
also pointed out that the lack of relation between time to
reperfusion and final infarct size in their study may be re-
flected by the selection bias in their study in which patients
with larger infarct were treated earlier.axis images show non viable inferior wall infarct (red
Fig. 3 e Delayed contrast enhanced short and vertical long axis images show evidence of viable inferior wall infarct with less
than 50% transmural enhancement (red arrows).
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size in patients with acute myocardial infarction (AMI) un-
dergoing percutaneous coronary intervention. They found
that anterior infarction, time to reperfusion, epicardial infarct
artery patency before and after reperfusion, male gender,
previousAMI, and failed thrombolytic therapywere important
predictors of infarct size after angioplasty in patients with
AMI. We also found that anterior location of infarct, time to
perfusion and failed thrombolysis were associated with larger
infarct size. No correlation with male sex was found in our
study like them probably due to the small sample size of the
study group. Their study was different from our study as they
took all patients of MI whereas our studywas limited to STEMI
patients with thrombolysis done with streptokinase. Infarct
size estimation in their study was through SPECT.
Edmund T. Hasche et al5 studied 61 patients who were
thrombolysed. Infarct size was estimated from the 12-lead
ECG according to a 32-point QRS score at day 7 post throm-
bolysis. They found through multivariate regression that sizeTable 1 e Baseline characteristics of the study population
(n ¼ 26).
Risk factor Frequency
Sex Male 20 (76.9%)
Female 6 (23.1%)
Smoking status Smokers 21 (80.8%)
Never smoked 5 (19.2%)
Diabetes Yes 5 (19.2%)
Hypertension Yes 9 (34.6%)
Dyslipidemia Yes 9 (34.6%)
Killip class Killip class I 12 (46.2%)
Killip class II 14 (53.4%)
Status of thrombolysis Successful 11 (42.3%)
Partial 2 (7.7%)
Failed 13 (50%)
Microvascular obstruction Yes (14) 53.8%
No (12) 46.2%
Infarcted region Anterior 9 (34.6%)
Lateral 4 (15.4%)
Inferior 13 (50%)of risk region, duration of ischemia, and degree of initial ST-
segment elevation were independent predictors of infarct
size, of which themost important variable was ischemia time.
Our study also shows that the infarct size is greater when time
to thrombolysis is increased. Although the method of infarct
determination between the two studies was different there is
agreement that increased duration of ischemia results in
larger infarct size.
E wu et al6 studied 122 patients with STEMI following acute
percutaneous reperfusion. They performed Cardiac magnetic
resonance imaging within 1 week following STEMI in 122
subjects. They found that acute infarct size correlated linearly
with the initial End systolic volume index (ESVI), end-diastolic
volume index (EDVI) and EF. Our study also has shown the
same relationship between these indices.
Pier Giorgio Masci et al7 have demonstrated that the
amount of necrotic myocardium strongly determines the
pattern of infarct healing, and regional and global LV remod-
eling. E wu et al6 had demonstrated that Infarct size, EF and
ESVI can predict the development of future cardiac events.
They found that acute infarct size, which is independent of LV
stunning and loading, directly relates to LV remodeling and is
a stronger predictor of future events than measures of LV
systolic performance. Stijntje D. Roes et al8 also found infarct
size on contrast-enhanced MRI to be superior to LVEF and LV
volumes for predicting long-term mortality in patients with
healed myocardial infarction.
In our study we also demonstrated the presence of
microvascular obstruction in 14 (53.8%) of our patients.
Katherine C.Wu et al9 studied 44 patients with acute MI 10þ 6
days after infarction. Microvascular obstruction was present
in 11 (25%) of their patients. Our results correlated with their
findings that microvascular obstruction was associated with
larger infarct size.
Gadolinium-based enhancement imaging is neither
necrotic nor fibrotic specific, and thus their concentration is
influenced by any conditions altering extracellular volume
such as myocardial edema. In a study Reimer et al demon-
strated that 2e4 days after reperfusion in the infarcted
Table 2 e Univariate analysis for infarct size.
Variable Coefficient Correlation coefficient f-test p Value
Age 0.262 ± 0.342 0.02 0.58 0.45
sex 3.36 ± 8.2 0.01 0.16 0.68
Smoker 18.611 ± 7.9 0.18 5.4 0.02
Diabetic 2.24 ± 8.8 0.00 0.06 0.8
Hypertension 2.130 ± 7.3 0.00 0.08 0.7
Dyslipidemic 9.14 ± 10.0 0.03 0.83 0.37
DBP 0.195 ± 0.27 0.02 0.51 0.48
SBP 0.004 ± 0.15 0.00 0.0006 0.98
RBS 0.11 ± 0.07 0.09 2.3 0.14
HR 0.30 ± 0.28 0.05 1.2 0.28
Status of thrombolysis 8.7 ± 3.1 0.24 7.5 0.01
Time to thrombolysis 2.7 ± 1.3 0.15 4.3 0.04
Killip class 12.7 ± 6.4 0.14 3.85 0.06
Infarct location 14.3 ± 2.49 0.58 33.0 0.000007
MO 16.0 ± 6.1 0.22 6.76 0.01
Viability status 23.1 ± 5.6 0.42 17.0 0.0004
Dysfunctional myocardium 0.6 ± 0.07 0.74 66.9 0.000000
Dysfunctional but viable 0.20 ± 0.42 0.01 0.24 0.62
LVEF 1.17 ± 0.1 0.73 65.7 0.000000
LVESV 0.20 ± 0.05 0.35 13.1 0.001
LVEDV 0.18 ± 0.06 0.25 8.0 0.009
SV 1.7 ± 0.29 0.58 33.5 0.000007
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conjunction with inflammation and hemorrhage.10 Thus this
technique may overestimate myocardial necrosis in the very
early phase when the volume of the infarcted tissue tends to
increase due to phenomena other than myocytes necrosis,
such as hyperemia, edema and inflammation cells infiltration.
Recent studies have shown a significant decrease in extent
of enhancement between day 1 and day 7 post-infarction,
suggesting an overestimation of the extent of irreversible
damage at very early imaging. These findings need to be
considered when performing late gadolinium, technique for
necrosis quantification in the early post-infarction phase.11
There were certain drawbacks in our study. The sample
size was small as it included STEMI patients receiving
thrombolytic therapy who were willing to participate in the
study. Only patients who were stable and could withstand the
cardiac MRI examination were included. The infarct size was
estimated within a week of myocardial infarct and may
represent an overestimation of the final infarct size due to
edema. Final infarct size can be assessed on follow up imaging
as initially there is infarct shrinkage. T2w imaging and
myocardial tagging in the patients could have added by esti-
mating the myocardium at risk. We did not incorporate these
as limited sequences were taken to reduce the time of acqui-
sition of relatively sick MI patients in MR gantry. Further these
sequences could have more relevant if follow up was done.
The interpretation of delayed gadolinium enhanced cardiac
MRI was done by a single observer and interpretation by
another observer could have reduced observer bias. The wall
motion abnormalities were visually assessed and could be
subjected to observer bias. Follow up of the patients could not
be taken due to financial constraints to the patients and
difficult geographical terrain in this part of the country, thus
estimation of final infarct size was not taken. This study was
intended as a preliminary study to evaluate various parame-
ters which can predict the size of acute infarct size on cardiacMRI as evaluated on thrombolysed STEMI patients. The infarct
size estimated may represent overestimation as could have
been seen on follow up imaging however we had put an effort
to evaluate all these factors in acute STEMI patients with
imaging done during their initial hospital stay. Further studies
evaluating these parameters with follow up of the patients to
determine the final infarct size are required.
To conclude, delayed contrast enhanced cardiac MRI ex-
amination can give both morphological and functional infor-
mation which have important therapeutic as well as
prognostic implications. We have tried to determine the fac-
tors influencing the acute infarct size in STEMI patients during
their initial hospital stay as determined by cardiac MRI which
can carry prognostic and therapeutic implications.Conflicts of interest
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